Published in Indian Pacing Electrophysiol J on November 15, 2011
Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era. Heart Rhythm (2007) 2.01
Transcoronary chemical ablation of ventricular tachycardia. Circulation (1989) 1.42
Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update. Circ Arrhythm Electrophysiol (2011) 1.19
Ventricular tachycardia arising from the aortomitral continuity in structural heart disease: characteristics and therapeutic considerations for an anatomically challenging area of origin. Circ Arrhythm Electrophysiol (2009) 1.06
Intracoronary ethyl alcohol or phenol injection ablates aconitine-induced ventricular tachycardia in dogs. J Am Coll Cardiol (1987) 1.05
Substrate characterization and catheter ablation for monomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol (2010) 0.96
Transcoronary chemical ablation of arrhythmias. Pacing Clin Electrophysiol (1992) 0.89
Transcoronary chemical ablation of ventricular tachycardia in chronic chagasic myocarditis. J Am Coll Cardiol (1992) 0.88
Transcoronary chemical ablation of ventricular tachycardia. Chin Med J (Engl) (1992) 0.81
Myocardial dissection following successful chemical ablation of ventricular tachycardia. Eur Heart J (1992) 0.81
Transcoronary ethanol ablation of experimental ventricular tachycardia after epicardial ice mapping and localizing. Chin Med J (Engl) (1991) 0.81
Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26
Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol (2011) 4.12
Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol (2005) 3.58
Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol (2005) 3.46
Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol (2009) 2.21
Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol (2009) 2.20
Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J (2008) 1.98
Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. J Am Coll Cardiol (2009) 1.98
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89
Ablation of severe drug-resistant tachyarrhythmia during pregnancy. J Cardiovasc Electrophysiol (2010) 1.84
Noninvasive panoramic mapping of human atrial fibrillation mechanisms: a feasibility report. J Cardiovasc Electrophysiol (2013) 1.79
Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J Am Coll Cardiol (2009) 1.74
Integration of merged delayed-enhanced magnetic resonance imaging and multidetector computed tomography for the guidance of ventricular tachycardia ablation: a pilot study. J Cardiovasc Electrophysiol (2012) 1.72
Validation of novel 3-dimensional electrocardiographic mapping of atrial tachycardias by invasive mapping and ablation: a multicenter study. J Am Coll Cardiol (2013) 1.67
SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet (2009) 1.64
Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J Cardiovasc Electrophysiol (2006) 1.63
Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation (2006) 1.63
Biventricular stimulation improves right and left ventricular function after tetralogy of Fallot repair: acute animal and clinical studies. Heart Rhythm (2009) 1.58
Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm (2008) 1.56
Identification of large families in early repolarization syndrome. J Am Coll Cardiol (2013) 1.50
Postmyocarditis ventricular tachycardia in patients with epicardial-only scar: a specific entity requiring a specific approach. J Cardiovasc Electrophysiol (2014) 1.50
Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges. Europace (2009) 1.47
A practical criterion for the rapid detection of single-loop and double-loop reentry tachycardias. J Cardiovasc Electrophysiol (2013) 1.45
Visualizing intramyocardial steam formation with a radiofrequency ablation catheter incorporating near-field ultrasound. J Cardiovasc Electrophysiol (2013) 1.38
Impact of a patent foramen ovale on paroxysmal atrial fibrillation ablation. J Cardiovasc Electrophysiol (2008) 1.37
Computed tomography-fluoroscopy overlay evaluation during catheter ablation of left atrial arrhythmia. Europace (2008) 1.14
Early recurrences after atrial fibrillation ablation: prognostic value and effect of early reablation. J Cardiovasc Electrophysiol (2008) 1.13
State of the art: catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2008) 0.98
Impact of catheter ablation of the coronary sinus on paroxysmal or persistent atrial fibrillation. J Cardiovasc Electrophysiol (2007) 0.97
Effect of catheter ablation for isolated paroxysmal atrial fibrillation on longitudinal and circumferential left ventricular systolic function. Am J Cardiol (2008) 0.94
Presence of ventricular dyssynchrony and haemodynamic impact of right ventricular pacing in adults with repaired Tetralogy of Fallot and right bundle branch block. Europace (2008) 0.91
Impact of pacing site on QRS duration and its relationship to hemodynamic response in cardiac resynchronization therapy for congestive heart failure. J Cardiovasc Electrophysiol (2014) 0.91
Clinical value of fibrillatory wave amplitude on surface ECG in patients with persistent atrial fibrillation. J Interv Card Electrophysiol (2009) 0.89
Noninvasive electrocardiographic mapping for prediction of tachycardia mechanism and origin of atrial tachycardia following bilateral pulmonary transplantation. J Cardiovasc Electrophysiol (2012) 0.89
Flutter localized to the anterior left atrium after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 0.89
Differences in twelve-lead electrocardiogram between symptomatic and asymptomatic subjects with short QT interval. Heart Rhythm (2008) 0.89
Incidence and prevention of cardiac tamponade complicating ablation for atrial fibrillation. Pacing Clin Electrophysiol (2005) 0.88
Wide complex tachycardia in a healthy young man. Europace (2008) 0.88
What next after failed septal ventricular tachycardia ablation? Indian Pacing Electrophysiol J (2012) 0.87
Radiofrequency puncture of the fossa ovalis for resistant transseptal access. Circ Arrhythm Electrophysiol (2008) 0.86
Images in cardiovascular medicine. Novel technique to prevent left phrenic nerve injury during epicardial catheter ablation. Circulation (2008) 0.85
Regional substrate ablation abolishes Brugada syndrome. J Cardiovasc Electrophysiol (2011) 0.85
Catheter ablation of atrial tachycardia following atrial fibrillation ablation. J Cardiovasc Electrophysiol (2009) 0.84
Catheter ablation for scar-related ventricular tachycardias. Curr Probl Cardiol (2009) 0.83
Sudden cardiac arrest: ECG repolarization after resuscitation. J Cardiovasc Electrophysiol (2010) 0.83
Ventricular fibrillation in loop recorder memories in a patient with early repolarization syndrome. Europace (2011) 0.82
Atrial structure and function 5 years after successful ablation for persistent atrial fibrillation: an MRI study. J Cardiovasc Electrophysiol (2014) 0.82
Atrial tachycardias arising from ablation of atrial fibrillation: a proarrhythmic bump or an antiarrhythmic turn? Cardiol Res Pract (2010) 0.82
Reliability and reproducibility of QRS duration in the selection of candidates for cardiac resynchronization therapy. J Cardiovasc Electrophysiol (2010) 0.81
High-density circumferential pulmonary vein mapping with a 20-pole expandable circular mapping catheter. Pacing Clin Electrophysiol (2005) 0.81
Relationship between perimitral and peritricuspid conduction times. Heart Rhythm (2007) 0.80
Eccentric activation of coronary sinus during perimitral flutter is a rare phenomenon: what is the mechanism? J Cardiovasc Electrophysiol (2010) 0.79
Balloon cryoablation for paroxysmal atrial fibrillation. Europace (2008) 0.78
Showing up channels for postinfarct ventricular tachycardia ablation. Pacing Clin Electrophysiol (2012) 0.78
Pre- and intra-procedural predictors of reverse remodeling after cardiac resynchronization therapy: an MRI study. J Cardiovasc Electrophysiol (2013) 0.78
Utility of the lateral fluoroscopic view for subxiphoid pericardial access. Circ Arrhythm Electrophysiol (2009) 0.78
Images in cardiovascular medicine. Coronary sinus tachycardia driving atrial fibrillation. Circulation (2004) 0.78
Imaging in catheter ablation for atrial fibrillation: enhancing the clinician's view. Europace (2008) 0.77
Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation. Europace (2009) 0.77
New strategies for ventricular tachycardia and ventricular fibrillation ablation. Expert Rev Cardiovasc Ther (2015) 0.76
The slowest, the worst: demonstrating the evidence. Heart Rhythm (2011) 0.75
Pathogenesis of AF: impact on intracardiac signals. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75
Differential sequential septal pacing: a simple maneuver to differentiate nodal versus extranodal ventriculoatrial conduction. Heart Rhythm (2013) 0.75
Has conduction to the pulmonary vein recovered? J Cardiovasc Electrophysiol (2008) 0.75
Cycle length slowing during mitral isthmus ablation. J Cardiovasc Electrophysiol (2008) 0.75
Management of atrial fibrillation. Discov Med (2010) 0.75
Management of Ventricular Arrhythmias in Patients with Mechanical Ventricular Support Devices. Curr Cardiol Rep (2015) 0.75
Unusual activation of the left atrium after ablation of a perimitral flutter: what is the mechanism? J Cardiovasc Electrophysiol (2008) 0.75
Effect of baroreflex stimulation using phenylephrine injection on ST segment elevation and ventricular arrhythmia-inducibility in Brugada syndrome patients. Europace (2009) 0.75
Ablation of Persistent Atrial Fibrillation: AF Termination is the End Point. Card Electrophysiol Clin (2012) 0.75
A long conduction time in the coronary sinus: has mitral isthmus line been blocked? J Cardiovasc Electrophysiol (2010) 0.75
Tachycardia-induced right ventricular cardiomyopathy: epicardial radiofrequency ablation of an unusual and unexpected ventricular tachycardia. J Cardiovasc Electrophysiol (2009) 0.75